Finding 977848 (2023-001)

Significant Deficiency Repeat Finding
Requirement
M
Questioned Costs
-
Year
2023
Accepted
2024-06-21

AI Summary

  • Core Issue: Contracts with subrecipients lack required disclosures as per 2 CFR 200.332.
  • Impacted Requirements: Significant deficiency in internal controls over compliance with federal regulations.
  • Recommended Follow-up: Update all subrecipient contracts to include necessary disclosures.

Finding Text

2023-001 – Communications with Subrecipients (repeat comment) Finding Type: Significant Deficiency in internal control over compliance / noncompliance Program: ALN 93.959 – COVID-19 - ARPA Treatment Criteria: As required by 2 CFR 200.332, the pass-through entity must communicate specific information to subrecipients, as applicable. Condition: Contracts with subrecipients did not include portions of required disclosures. Cause/Effect: Inadequate internal controls over compliance. Select contracts were not in compliance with 2 CFR 200.332. Questioned Cost: None. Recommendation: We recommend that the PIHP update all contracts with subrecipients to include required language. View of Responsible Official: Management is in agreement with this recommendation.

Categories

Subrecipient Monitoring Internal Control / Segregation of Duties Significant Deficiency

Other Findings in this Audit

  • 401406 2023-001
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $2.54M
93.958 Block Grants for Community Mental Health Services $184,776
93.959 Block Grants for Prevention and Treatment of Substance Abuse $56,693